Page last updated: 2024-08-24

lamivudine and Minimal Disease, Residual

lamivudine has been researched along with Minimal Disease, Residual in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arcaini, L; Bruno, R; Lucioni, M; Merli, M; Paulli, M; Rattotti, S; Riboni, R; Vercelli, A	1

Other Studies

1 other study(ies) available for lamivudine and Minimal Disease, Residual

Article	Year
Regression of indolent B-cell lymphoma after Lamivudine prophylaxis of hepatitis B virus infection. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jun-20, Volume: 29, Issue:18 Topics: Antiviral Agents; Asymptomatic Diseases; Bone Marrow; Carrier State; Cell Transformation, Viral; Disease Progression; Female; Genes, bcl-2; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, B-Cell; Lymphoma, Follicular; Middle Aged; Neoplasm, Residual; Remission Induction; Splenic Neoplasms	2011

Article

Year

Regression of indolent B-cell lymphoma after Lamivudine prophylaxis of hepatitis B virus infection.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jun-20, Volume: 29, Issue:18

Topics: Antiviral Agents; Asymptomatic Diseases; Bone Marrow; Carrier State; Cell Transformation, Viral; Disease Progression; Female; Genes, bcl-2; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, B-Cell; Lymphoma, Follicular; Middle Aged; Neoplasm, Residual; Remission Induction; Splenic Neoplasms

2011